
Chemical and Pharmaceutical Bulletin p. 1724 - 1733 (1995)
Update date:2022-09-26
Topics:
Uno
Ozeki
Koga
Chu
Okada
Tamura
Igawa
Unemi
Kido
Nishi
A search for potent inhibitors of release of 12(S)- hydroxyeicosatetraenoic acid (12-HETE), which plays an important role in the pathogenesis of various circulatory disorders and arteriosclerosis, led us to 6-[4-(1-cyclohexyl-5-tetrazolyl)butoxy]-3,4-dihydro-2(1H)-quinolinone (cilostazol) and 2(1H)-quinolinone derivatives having an azole group in the side chain. Many 2(1H)-quinolinone derivatives were synthesized and tested in vitro for the inhibitory activity in human platelets. 3,4-Dihydro-6-[3-(1-o- tolylimidazol-2-yl)sulfinylpropoxy]-2(1H)-quinolinone (5k) was found to be one of the most potent inhibitors of 12-HETE release, being more potent than esculetin. In addition, the sulfoxide 5k showed in vivo inhibitory activity on platelet adhesion in rats. Since 5k is racemic, the enantiomers were prepared and their potencies were compared in vitro and in vivo. (S)-(+)-5k had the best pharmacological profile and was selected as a candidate drug for further development. The structure-activity relationships are discussed.
View MoreShijiazhuang Yunxuan Im&Export Co.,Ltd.
Contact:+86-311-83037514
Address:No.6 Hongbin Road
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Contact:+86-532-80762375
Address:No. 6, Hongkong Middle Road, Qingdao, China
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796908173
Address:No 18 Guoqiao Road
Doi:10.1016/j.jorganchem.2008.11.043
(2009)Doi:10.1002/chir.20722
(2010)Doi:10.1021/jo00248a005
(1988)Doi:10.1002/bkcs.10286
(2015)Doi:10.1021/jm900095y
(2009)Doi:10.1021/jo01102a603
(1958)